The prolactin response to sulpiride in major depression: The role of the D2 receptor in depression

European Neuropsychopharmacology

Volumn 11, Issue 3, 2001, Pages 215-220

  Verbeeck, W J C ^a   Berk, M ^c,d   Paiker, J ^a   Jersky, B ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b University of Sonoma   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d Barwon Health   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; PROLACTIN; SULPIRIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; MESOLIMBIC DOPAMINERGIC SYSTEM; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL;

ADULT; ANALYSIS OF VARIANCE; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; DOPAMINE ANTAGONISTS; HUMANS; MALE; PROLACTIN; RECEPTORS, DOPAMINE D2; SULPIRIDE;

EID: 0034957862     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(01)00086-4     Document Type: Article

References (45)

1. Prolactin response to the dopamine antagonist metoclopramide, in depression
2. Dopaminergic and opioidergic mediators of tryciclics in the learned helplessness paradigm
3. Involvement of serotonin and dopamine in the mechanism of novel antidepressant drugs
4. Reduced dopamine turnover in the basal ganglia of depressed suicides
5. Amisulpiride versus amineptine and placebo for the treatment of dysthymia
6. Chronic antidepressant drug treatment reduces turning behaviour and increases DA levels in the medial prefrontal cortex
7. Electroconvulsive therapy and the brain: Evidence for increased dopamine mediated responses
8. 2 receptors in the brain measured with SPECT
9. 3 receptors on prolactin secretion and the activity of the tuberoinfundibular dopamine neurons
10. Prolactin response to sulpiride before and after sleep deprivation in depression
11. Reduced cerebrospinal HVA concentration and HVA/5-HIAA ratios in suicide attempters
12. CNS stimulant potentiation of mono-amine oxidase inhibitors in the treatment of refractory depression
13. Prolactin and neuroleptic drugs
14. Dopaminergic agonist nomifensine compared with amitriptyline: A double blind clinical trial in acute primary depression
15. Dopaminergic sensitivity and prediction of antidepressant response
16. Drug-induced changes in prolactin secretion
17. The prolactin response to metoclopramide is increased in depression and in euthymic rapid cycling bipolar patients
18. Blunted prolactin response
19. 2 occupancy
20. Role of dopaminergic system in depression
21. 2-receptors
22. 123I]IBZM SPECT
23. Striatal dopamine transporter density in major depression
24. 2 receptors in striatum and anterior cingulate gyrus in major depression
25. Amisulpiride versus imipramine and placebo in dysthymia and major depression. Amisulpiride study group
26. A fixed dose (300 mg) efficacy study of bupropion and placebo in depressed out patients
27. A dopaminergic hypothesis of major depression
28. Depression in the patient with Parkinson's disease
29. Decreased Dopamine-beta-hydroxylase activity in unipolar geriatric delusional depression
30. Effects of fluvoxamine treatment on the in vivo binding of [F-18]FESP in drug naive depressed patients: a pet study
31. 2 receptor binding in limbic forebrain associated with chronic mild stress induced anhedonia and its reversal by imipramine
32. 2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder
33. Serotonin-dompamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo
34. Dopaminergic hypothesis for retarded depression: A symptom profile for predicting therapeutical responses
35. Antidepressant action of sulpiride. Results of a placebo-controlled double-blind trial
36. The role of Dopamine in depression
37. Tyrosine hydroxylase gene associated with depressive symptomatology in mood disorder
38. 2 binding in depression
39. In vivo microdialysis assessment of extracellular serotonin and dopamine levels in awake monkeys during sustained fluoxetine administration
40. A randomised double blind group comparative study of sulpiride and amitriptylline in affective disorder
41. A controlled comparison of flupenthixol deconoate injections and oral amitriptyline in depressed out-patients
42. 2 dopamine receptor binding in humans measured with positron emission tomography
43. Chronic administration of L-sulpiride at non-neuroleptic doses reduces the duration of immobility in experimental models of 'depressive-like' behaviour
44. Dopaminergic mechanisms in depression and mania